Teladoc Health, Inc.

NYSE:TDOC

Medical - Healthcare Information Services

Healthcare
$8.06 +2.57%

+$0.20 today

Market cap
$1.47B
Beta
2.14
P/E (TTM)
-8.1
EPS (TTM)
-$0.96
52W Low $4.40High $9.77

Volume 3.96M

Average 4.68M

TDOC Pre-Tax Margin

Income before tax as a percentage of revenue.

Teladoc Health, Inc.NYSE: TDOC

Pre-Tax Margin · Q1 FY2026 · quarter ended Mar 2026

Pre-tax margin widens to -9.9%

Pre-tax margin was -9.9% in Q1 FY2026, up 7.8 pp from a year earlier. On a trailing-twelve-month basis it was -7.4%, up 32.8 pp year over year. Over 3 fiscal years it widened by 558.4 pp.

Context

  • Pre-tax margin widened in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-9.9%-4.7 pp QoQ
Last fiscal yearDec 2025
-9.3%+29.4 pp YoY
LTMMar 2026
-7.4%+32.8 pp YoY
Pre-Tax Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+7.8 pp——
1 year+29.4 pp——
3 years+558.4 pp——
5 years——
10 years——

Pre-Tax Margin history

Percent of revenue · from the income statement

Latest · FY2025
-9.3%
Year-over-year change
+29.4pp

Pre-Tax Margin vs competitors

How TDOC compares with its peers on the latest reported figures

  • TDOC's LTM Mar 2026 pre-tax margin of -7.4% is the 5th highest of the 10 companies compared; the peer median is -21.1%.
  • Its year-over-year change of +32.8 pp is the 3rd highest of 10, against a peer median of +2.0 pp.
  • Over three fiscal years its change of +558.4 pp compares with a peer median of +4.3 pp.
TDOC Competitors Peer median
Pre-Tax Margin for TDOC and competitors
Company Period LTM level YoY 3-year change
PGNYProgyny, Inc.LTM Jun 20269.1% +2.0 pp+4.3 pp
OMCLOmnicell, Inc.LTM Mar 20263.1% +0.1 pp+1.1 pp
PHRPhreesia, Inc.LTM Apr 2026-0.2% +8.9 pp+60.7 pp
OMDAOmada HealthLTM Mar 2026-2.2% +17.6 pp+76.4 pp
TDOCTeladoc Health, Inc.LTM Mar 2026-7.4% +32.8 pp+558.4 pp
SDGRSchrödinger, Inc.LTM Sep 2026-21.1% +46.8 pp+42.4 pp
AZTAAzenta, Inc.LTM Sep 2026-24.3% -23.6 pp-19.7 pp
EVOEvotec SELTM Mar 2026-24.3% -1.8 pp+4.2 pp
NVCRNovoCure LimitedLTM Mar 2026-26.0% -5.1 pp-5.6 pp
IMNMImmunome, Inc.FY2025-3060.0% +180.4 pp—
PHVSPharvaris N.V.FY2025— ——
Peer median (excluding TDOC) -21.1%+2.0 pp+4.3 pp

Competitors are the stored peer set for TDOC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.03B2.41B2.6B2.57B2.53B
Cost of Revenue650.26M743.99M760.03M751.27M771.59M
Gross Profit1.38B1.66B1.84B1.82B1.76B
Gross Margin68.0%69.1%70.8%70.8%69.5%
Research & Development311.88M333.63M348.52M307.27M277.92M
Selling, General & Admin1.11B1.3B1.37B1.35B1.09B
Operating Expenses1.65B15.32B2.09B2.84B2.02B
Depreciation & Amortization207.57M209.93M254.11M240.51M363.12M
EBITDA(31.42M)(7.54M)43.61M31.72M147.3M
EBITDA Margin-1.5%-0.3%1.7%1.2%5.8%
Operating Income(265.63M)(13.65B)(248.55M)(1.02B)(262.96M)
Operating Margin-13.1%-567.3%-9.6%-39.7%-10.4%
Interest Income776K12.67M46.78M57.07M36.77M
Interest Expense81.14M21.94M22.28M23.8M19.71M
Other Income / Expenses(119.03M)(10.13M)28.95M27.23M27.43M
Income Before Tax(384.66M)(13.66B)(219.61M)(993.65M)(235.53M)
Pre-Tax Margin-18.9%-567.7%-8.4%-38.7%-9.3%
Income Tax Expense44.14M(3.81M)760K7.59M(35.21M)
Net Income(428.79M)(13.66B)(220.37M)(1B)(200.32M)
Net Margin-21.1%-567.5%-8.5%-39.0%-7.9%
EPS (Basic)(2.73)(84.60)(1.36)(5.87)(1.14)
EPS (Diluted)(2.73)(84.60)(1.34)(5.87)(1.14)
Weighted Avg Shares156.94M161.46M162.17M170.56M176.22M
Weighted Avg Shares (Diluted)156.94M161.46M164.58M170.56M176.22M

Teladoc Health, Inc.

NYSE:TDOC

Intrinsic Alpha fair value

Locked

Current Price

$8.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.